SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
VIVO
--
0.00%
--
Week 23 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
Seeking Alpha - Article · 5d ago
Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference
GlobeNewswire · 05/29 13:00
Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
GlobeNewswire · 05/20 21:20
Top Stock Picks for Week of May 11, 2020
Zacks · 05/12 21:20
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 70 companies set new 52-week highs.
Benzinga · 05/11 14:29
Stock market live updates: Dow falls 100, second wave fears
A conversation about the latest market-moving news, including new coronavirus cases being reported in Japan and Singapore.
CNBC.com · 05/11 11:34
Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q2 2020 Results-Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 20:45
Edited Transcript of VIVO earnings conference call or presentation 8-May-20 2:00pm GMT
Thomson Reuters StreetEvents · 05/09 00:35
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 60 companies set new 52-week highs.
Benzinga · 05/08 14:32
Meridian Bioscience, Inc. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha - Article · 05/08 14:08
Meridian Bioscience (VIVO) Q2 Earnings and Revenues Surpass Estimates
Zacks · 05/08 13:55
Earnings dominate premarket gainers
Seeking Alpha - Article · 05/08 13:15
Meridian Bio +12% on robust Life Science sales; guidance raised
Seeking Alpha - Article · 05/08 12:26
Recap: Meridian Bioscience Q2 Earnings
Shares of Meridian Bioscience (NASDAQ:VIVO) rose 8.4% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 21.05% year over year to $0.23, which beat the estimate of $0.08.
Benzinga · 05/08 12:02
Meridian Raises FY20 Guidance: Adj. EPS $0.70-$0.75, Sales $230M-$236M
Benzinga · 05/08 11:36
Meridian Bioscience Q2 EPS $0.230 Beats $0.080 Estimate, Sales $57.300M Beat $49.260M Estimate
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.230 per share which beat the analyst consensus estimate of $0.080 by 187.5 percent. This is a 21.05 percent increase over earnings of $0.190 per share
Benzinga · 05/08 11:36
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 55 companies made new 52-week highs.
Benzinga · 05/07 14:33
Why Meridian Bioscience Stock Shot Up Nearly 13% Today
The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.
Motley Fool · 05/06 21:51
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
Zacks · 05/01 17:30
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience
GlobeNewswire · 04/30 15:51